Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients | Zendy

Jianling Liu | Zendy; Haichen Wang | Zendy; Ziyan Huang | Zendy; Xiaoyan Tao | Zendy; Jun Li | Zendy; Yongmei Hu | Zendy; Qingya Dou | Zendy; Mingxiang Zou | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients

Author(s) -

Jianling Liu,

Haichen Wang,

Ziyan Huang,

Xiaoyan Tao,

Jun Li,

Yongmei Hu,

Qingya Dou,

Mingxiang Zou

Publication year - 2019

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.11189

Subject(s) - medicine , bacteremia , klebsiella pneumoniae , neutropenia , carbapenem , multivariate analysis , mortality rate , risk factor , hematology , intensive care medicine , antibiotics , microbiology and biotechnology , chemotherapy , biology , biochemistry , escherichia coli , gene

Carbapenem-resistant Klebsiella pneumoniae (KP) serves as a major threat to onco-hematological patients, resulting in great morbidity and mortality. The purpose of our study was to identify the risk factors for KP bloodstream infections (BSIs) and mortality in onco-hematological patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research